Mounjaro Medical Facts: What the Prescription Actually Involves

You've read the headlines — here's what the medicine is actually doing

Picture this: it's mid-morning, you've had breakfast an hour ago but you're already thinking about lunch. That persistent hunger signal is, in large part, hormonal. Mounjaro works by mimicking two gut hormones (GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1)) that your body releases naturally after eating. By activating both receptor pathways simultaneously, tirzepatide slows the rate at which the stomach empties, dials down appetite signals from the brain, and helps stabilise blood-sugar levels after meals.

This dual mechanism is what separates Mounjaro from the other medicines in the tirzepatide class discussion, and from the single-pathway GLP-1 medicines. It doesn't replace the hormones permanently; it occupies the receptors once a week, via a once-weekly subcutaneous injection, for as long as treatment continues. The prescriber (not the medicine) decides when and whether to increase the dose, based on how your body responds. The NHS medicines page for tirzepatide covers the pharmacology in plain language if you want to go deeper.

Clinical trials under the SURMOUNT programme, involving thousands of adults with obesity, reported an average body-weight reduction of around 20 to 21 percent over 72 weeks at the 15 mg maintenance dose. Those figures come from a controlled setting with structured lifestyle support alongside the medicine, worth keeping in mind when weighing them against real-world expectations.

What the prescriber is assessing when Mounjaro comes up

A medical assessment for Mounjaro isn't a box-ticking exercise. The prescriber is building a picture: your current BMI, any existing conditions, your medication list, your weight history and your goals. The licensed eligibility threshold is a BMI of 30 or higher, or 27 or higher if you have at least one weight-related condition, for example, high blood pressure, dyslipidaemia, prediabetes, obstructive sleep apnoea, or established cardiovascular disease. For some ethnic backgrounds, UK clinical guidance applies a threshold 2.5 kg/m² lower; if that applies to you, it's worth raising at consultation.

The prescriber is also screening for contraindications. A personal or family history of medullary thyroid carcinoma or MEN2 syndrome, previous acute pancreatitis, and certain gastrointestinal conditions all require careful consideration. Mounjaro is not licensed for use during pregnancy, while breastfeeding, or when trying to conceive, and it is not authorised for anyone under 18. If you take an oral contraceptive, the prescriber will flag that tirzepatide's effect on gastric emptying can reduce pill absorption, a barrier method is advised for the first four weeks of treatment and for four weeks after each dose increase, as NHS England's guidance on weight-management injections explains.

If you're curious about how Mounjaro sits alongside the broader landscape of weight-loss medications, that context is covered separately. The clinical assessment is the point at which all of those questions get personal answers.

Side effects the prescriber will walk you through

The most common side effects are gastrointestinal: nausea, loose stools, constipation, indigestion and burping. They tend to be most noticeable in the first days after starting or after a dose increase, and for many people they settle within a couple of weeks as the body adjusts. Fatigue, headache, dizziness and injection-site reactions are also reported. None of this is alarming in itself, but the prescriber needs to know about it, which is why aftercare access matters as much as the consultation itself.

There are symptoms that need urgent medical attention. Severe or persistent stomach pain that radiates to the back, with or without vomiting, can be a sign of pancreatitis. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines, if that happens, stop the injection and get medical help the same day. Gallbladder symptoms, signs of a serious allergic reaction, and heavy dehydration from protracted vomiting or diarrhoea are also situations where you don't wait.

Patients can report any suspected side effects directly at the MHRA's Yellow Card scheme. It's a simple online form and the data genuinely feeds into ongoing medicine safety monitoring. Worth knowing about before you start, not only if something goes wrong.

Getting Mounjaro: private prescription and what that process looks like

Mounjaro is available on the NHS, but current access is phased and the eligibility bar is high, broadly BMI 40 or above with multiple serious comorbidities at this stage, with criteria broadening gradually through 2026 and 2027. For most people who meet the licensed eligibility threshold, a private prescription is the practical route.

At nume, a GPhC-registered Independent Prescriber reads your consultation the same day, a real clinician, not an automated system. Identity is verified with photo ID, and weight is confirmed on a short video call. If the prescriber decides Mounjaro is clinically appropriate, orders placed before midday go out the same day for free next-working-day delivery via DPD, in plain packaging. There's one transparent price that covers the consultation, prescription and delivery; no subscription is set up without your active choice at each repeat, and every repeat order goes through a fresh clinical review.

You can check which treatments you may be eligible for on the weight-loss treatments page, and the full Mounjaro overview has more detail if you want to read the broader picture before starting a consultation. If you want to understand what the Mounjaro medication involves before committing, including how it is supplied and used, that is covered in detail separately. A full breakdown of what type of medication Mounjaro is is also available if you're researching from a more clinical angle, and if you have questions about the medical name behind Mounjaro, including how tirzepatide relates to the brand, that page explains the distinction clearly. Check your eligibility and a prescriber will take it from there.